# Management of Catatonic Features in Adolescents With Profound Autism

> **NCT07498387** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Tanta University** · enrollment: 30 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Catatonia

## Interventions

- **DRUG:** Intranasal Midazolam (Benzodiazepine Challenge Test)
- **DRUG:** Oral Clonazepam
- **DEVICE:** Electroconvulsive Therapy (ECT)
- **OTHER:** Standard Assessments and Monitoring

## Key facts

- **NCT ID:** NCT07498387
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-08
- **Final completion:** 2026-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07498387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07498387, "Management of Catatonic Features in Adolescents With Profound Autism". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07498387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*